Literature DB >> 21778788

Lim1, an embryonal transcription factor, is absent in multicystic renal dysplasia, but reactivated in nephroblastomas.

Barbara Guertl1, Upeka Senanayake, Elisa Nusshold, Ivo Leuschner, Sebastian Mannweiler, Birgit Ebner, Gerald Hoefler.   

Abstract

OBJECTIVE: Lim1 (Lim homeobox 1) plays an important role during rodent renal development; however, its rolein human kidney development and disease is still unclear.
METHODS: We investigated LIM1 expression during human renal development, in dysplastic kidneys and in renal neoplasms using immunohistochemistry. RNA levels in renal carcinomas were determined by quantitative RT-PCR, and the potential roles of LIM1 in mesenchymal-epithelial transition and cell cycle were investigated in a cell culture model.
RESULTS: LIM1 was detected in pretubular aggregates, S-shaped and comma-shaped bodies as well as immature glomeruli between 10 and 30 weeks of gestation. Eleven dysplastic kidneys showed no expression of LIM1. In contrast, 12 of 32 nephroblastomas showed nuclear positivity. One regressive nephroblastoma had diffuse expression of LIM1 in tubular structures, all others showed focal positivity in mesenchymal, blastemal and epithelial structures. Renal cell carcinomas revealed no expression of LIM1. Overexpression of LIM1 in a cell culture model led to an increase in KERATIN7 expression but no change in the cell cycle.
CONCLUSION: Our study supports the concept of a causative role of LIM1 deficiency in the development of multicystic kidney. In a small subset of nephroblastomas with a more diffuse expression pattern LIM1 might also contribute to the pathogenesis of these lesions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778788     DOI: 10.1159/000326769

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  3 in total

1.  The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.

Authors:  Imène Hamaidi; Catherine Coquard; Sabrina Danilin; Valérian Dormoy; Claire Béraud; Sylvie Rothhut; Mariette Barthelmebs; Nadia Benkirane-Jessel; Véronique Lindner; Hervé Lang; Thierry Massfelder
Journal:  Oncogene       Date:  2018-08-03       Impact factor: 9.867

2.  Sciellin is a marker for papillary renal cell tumours.

Authors:  Anetta Nagy; Daniel Banyai; David Semjen; Tamas Beothe; Gyula Kovacs
Journal:  Virchows Arch       Date:  2015-10-16       Impact factor: 4.064

3.  LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.

Authors:  Ye Tian; Fang Wen; Shuo Wang; Na Lv
Journal:  Clinics (Sao Paulo)       Date:  2022-09-15       Impact factor: 2.898

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.